Business Context and Reporting Period
GridAI Technologies Corp. (formerly Entero Therapeutics, Inc.) filed a Current Report on Form 8-K dated April 1, 2026. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol GRDX. The report addresses a triggering event related to a direct financial obligation.
Key Financial Metrics and Obligations
The filing details a specific debt obligation rather than general operating metrics:
- Outstanding Principal: $700,000 received under a Revolving Loan Agreement dated January 27, 2025.
- Total Amount Demanded: $1,014,675, comprising principal, accrued interest, and a 20% default penalty.
- Lender: 1396974 BC Ltd.
- Maturity Date: January 31, 2026.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or overall liquidity beyond the specific loan details.
Material Changes and Events
On April 1, 2026, the Company received a demand letter from the Lender's counsel asserting a default on the Revolving Loan Agreement. The default occurred because the Maturity Date of January 31, 2026, passed without repayment of the principal and accrued amounts. Consequently, the Lender demanded immediate payment of the total sum of $1,014,675.
Management Commentary and Outlook
Management states that the Company is currently evaluating the effects of this default event. The Company is in active discussions with the Lender regarding the outstanding obligation. No specific guidance, risk factors beyond the immediate default, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the current status of negotiations between GridAI Technologies Corp. and 1396974 BC Ltd.
- Confirm whether the Company has secured additional funding to satisfy the $1,014,675 demand.
- Review subsequent filings for any updates on the default status or potential restructuring of the debt.
- Assess the impact of this default on the Company's ability to meet other financial obligations.